Source: Virtual Congress 2021 – Pulmonary embolism: special situations



Rating:

Share or cite this content

Citations should be made in the following way:
M. Rodger (Montreal, Canada). Management of recurrent PE in patients on anticoagulant therapy. Virtual Congress 2021 – Pulmonary embolism: special situations

Member's Comments

No comment yet.

Related content which might interest you: Management of bleeding during anticoagulant therapy Source: International Congress 2019 – Update on anticoagulant therapy: controversy and progress Year: 2019 Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007 Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures Source: Eur Respir Rev, 26 (145) 170020; 10.1183/16000617.0020-2017 Year: 2017 Risk factors for recurrences in patients with idiopathic pulmonary embolism after withdrawal of long-term anticoagulation Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006 Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism Source: Eur Respir J 2016; 48: 1360-1368 Year: 2016 Treatment of CTEPH and anticoagulation of choice Source: ERS Course 2019 - Masterclass in pulmonary embolism Year: 2019 Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016 Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease Source: Annual Congress 2004 - Treatment of pulmonary hypertension Year: 2004 Initial anticoagulant treatment and home treatment of PE Source: ERS Course 2019 - Masterclass in pulmonary embolism Year: 2019 Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli Source: ERJ Open Res, 7 (1) 00554-2020; 10.1183/23120541.00554-2020 Year: 2021 Treatment of high-risk PE and the role of catheter-directed therapies Source: ERS Course 2019 - Masterclass in pulmonary embolism Year: 2019 Safety of corticosteroid therapy in patients with pulmonary sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 The outcome of anticoagulation alone therapy for patients with submassive pulmonary embolism Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 High incidence of bacteraemia complicating iv prostaglandin therapy in patients with pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 371s Year: 2002 Thrombolytic therapy in cases with massive pulmonary thromboembolism Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005 Safety and efficacy of immunoadsorption as an add-on to medical treatment in patients with idiopathic pulmonary arterial hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Efficacy of oral add-on therapy in patients with pulmonary hypertension Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment Source: International Congress 2017 – MDRTB: detection and management Year: 2017 Successful pregnancy outcome in patients with pulmonary arterial hypertension receiving prostayclin therapy Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004